Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
111, Inc. Regains Compliance with NASDAQ Requirement
08:00am, Tuesday, 11'th Feb 2025
SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indu
Nasdaq Gains 1% As Nvidia, Broadcom Surge: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
03:25am, Tuesday, 11'th Feb 2025
The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index moved to the “Neutral” zone on Monday.
Odysight.ai Announces the Pricing of $21.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
08:00pm, Monday, 10'th Feb 2025
Odysight.ai common stock to begin trading on Nasdaq Tuesday, February 11, 2025, under the symbol “ODYS” OMER, Israel, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (Nasdaq: ODYS) (“Odysigh
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00pm, Monday, 10'th Feb 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:44pm, Monday, 10'th Feb 2025
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-
Nasdaq 100: Nvidia and Broadcom Surge Today—Is This the Start of a New Uptrend?
12:20pm, Monday, 10'th Feb 2025
Stock market rallies as Nvidia, Broadcom, and steel stocks surge. Can momentum continue, or will inflation concerns and Fed policy weigh on US indices?
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss
12:05pm, Monday, 10'th Feb 2025
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Monday.
S&P 500 and Nasdaq 100: US Stocks Rise as Traders Look Past Tariff Threat
10:03am, Monday, 10'th Feb 2025
S&P 500 and Nasdaq rise despite tariff uncertainty. Traders await Powell's speech and CPI data for insights on inflation, interest rates, and market outlook.
Nasdaq, Inc. Announces Cash Tender Offers for Up to $200 Million Outstanding Debt Securities
08:05am, Monday, 10'th Feb 2025
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) (“Nasdaq” or the “Company”) today announced its offers to purchase for cash up to an aggregate principal amount of $200,
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
08:00am, Monday, 10'th Feb 2025
BRAINTREE, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 6,103,289 shares of
Can a $50,000 Investment in the Nasdaq-100 Today Turn Into $1 Million by the Time You Retire?
05:06am, Sunday, 09'th Feb 2025
Investors will find many of the best growth stocks in the world on the Nasdaq exchange. An even more exclusive club is in the Nasdaq-100 index, which includes the largest nonfinancial stocks on the ex
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:30pm, Friday, 07'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 07'th Feb 2025
BRISBANE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeuti
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 07'th Feb 2025
CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives o
Brera Holdings Announces Anticipated Receipt of Nasdaq Additional Deficiency Notice
04:15pm, Friday, 07'th Feb 2025
Dublin, Ireland, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or “the Company”) (Nasdaq: BREA), an Ireland-based, Nasdaq-listed, international holding company focused
